200 related articles for article (PubMed ID: 10835438)
1. Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.
Clark WM; Raps EC; Tong DC; Kelly RE
Stroke; 2000 Jun; 31(6):1234-9. PubMed ID: 10835438
[TBL] [Abstract][Full Text] [Related]
2. Cervene in acute ischemic stroke: results of a double-blind, placebo-controlled, dose-comparison study.
Clark W; Ertag W; Orecchio E; Raps E
J Stroke Cerebrovasc Dis; 1999; 8(4):224-30. PubMed ID: 17895169
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of Cervene, a kappa receptor-selective opioid antagonist, in acute ischemic stroke.
Clark WM; Coull BM; Karukin M; Hendin B; Kelley R; Rosing H; Zachariah S; Winograd M; Raps E; Walshe T; Singer S; Mettinger KL
J Stroke Cerebrovasc Dis; 1996; 6(1):35-40. PubMed ID: 17894963
[TBL] [Abstract][Full Text] [Related]
4. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
[TBL] [Abstract][Full Text] [Related]
6. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
Grotta J
Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
[TBL] [Abstract][Full Text] [Related]
7. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
8. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
Albers GW; Goldstein LB; Hall D; Lesko LM;
JAMA; 2001 Dec; 286(21):2673-82. PubMed ID: 11730442
[TBL] [Abstract][Full Text] [Related]
9. Nalmefene. Alcohol dependence: no advance.
Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
[TBL] [Abstract][Full Text] [Related]
10. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
Mann K; Bladström A; Torup L; Gual A; van den Brink W
Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.
Mason BJ; Ritvo EC; Morgan RO; Salvato FR; Goldberg G; Welch B; Mantero-Atienza E
Alcohol Clin Exp Res; 1994 Oct; 18(5):1162-7. PubMed ID: 7847600
[TBL] [Abstract][Full Text] [Related]
12. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
13. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
Gual A; He Y; Torup L; van den Brink W; Mann K;
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
[TBL] [Abstract][Full Text] [Related]
14. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.
Dyker AG; Lees KR
Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426
[TBL] [Abstract][Full Text] [Related]
15. Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety study.
Rosen DA; Morris JL; Rosen KR; Nelson ER; Steelman RJ; Gustafson RA; Wilhelm JA; Chang CT; Thackara JW; Frye RF
Pharmacotherapy; 2000 Jul; 20(7):745-9. PubMed ID: 10907964
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose.
Kaplan JL; Marx JA; Calabro JJ; Gin-Shaw SL; Spiller JD; Spivey WL; Gaddis GM; Zhao N; Harchelroad FP
Ann Emerg Med; 1999 Jul; 34(1):42-50. PubMed ID: 10381993
[TBL] [Abstract][Full Text] [Related]
17. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB
Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
[TBL] [Abstract][Full Text] [Related]
19. Nalmefene. JF 1, nalmetrene, NIH 10365, ORF 11676, Arthrene, Cervene, Incystene, Revex.
Drugs R D; 1999 Jan; 1(1):32-3. PubMed ID: 10565979
[No Abstract] [Full Text] [Related]
20. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.
van den Brink W; Strang J; Gual A; Sørensen P; Jensen TJ; Mann K
Expert Opin Drug Saf; 2015 Apr; 14(4):495-504. PubMed ID: 25652768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
